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Abstract
The aim of the present study was to evaluate the definition of oral leukoplakia, proposed by the WHO in 2005 and 
taking into account a previously reported classification and staging system, including the use of a Certainty factor 
of four levels with which the diagnosis of leukoplakia can be established.
In the period 1997-2012 a hospital-based population of 275 consecutive patients with a provisional diagnosis of 
oral leukoplakia has been examined. In only 176 patients of these 275 patients a firm diagnosis of leukoplakia has 
been established based on strict clinicopathological criteria. The 176 patients have subsequently been staged using 
a classification and staging system based on size and histopathologic features.
For use in epidemiological studies it seems acceptable to accept a diagnosis of leukoplakia based on a single oral 
examination (Certainty level 1). For studies on management and malignant transformation rate the recommen-
dation is made to include the requirement of histopathologic examination of an incisional or excisional biopsy, 
representing Certainty level 3 and 4, respectively. This recommendation results in the following definition of oral 
leukoplakia: “A predominantly white lesion or plaque of questionable behaviour having excluded, clinically and 
histopathologically, any other definable white disease or disorder”. Furthermore, we recommend the use of strict 
diagnostic criteria for predominantly white lesions for which a causative factor has been identified, e.g. smokers’ 
lesion, frictional lesion and dental restoration associated lesion.  
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Introduction
The estimated prevalence of oral leukoplakia world-
wide is approximately 2%,(1) with an annual malignant 
transformation rate into oral squamous cell carcinoma 
(OSCC) of approximately 1%. (2) In 1978, oral leuko-
plakia was defined by the World Health Organization 
(WHO) as: ‘a white patch or plaque that cannot be 
characterized clinically or pathologically as any other 
disease’. (3) At an international conference in 1984, 
an addition was made to the 1978 WHO definition: 
‘oral leukoplakia is not associated with any physical or 
chemical causative agent except the use of tobacco’.(4) 
Thereafter, in 1986, the definition of oral leukoplakia 
has been changed into: ‘a predominantly white lesion 
of the oral mucosa that cannot be characterized as any 
other definable disease’. (5) In 1997, the phrase: ‘any 
other definable disease’ was replaced by ‘any other de-
finable lesion’. (6)
In 2002, it was recommended to make a distinction be-
tween a provisional clinical diagnosis of oral leukopla-
kia and a definitive one. (7) A provisional diagnosis was 
made when a lesion at the initial clinical examination 
could not be clearly diagnosed as either leukoplakia or a 
definable lesion. In case of a provisional clinical diagno-
sis, Certainty factor 1 was assigned. A definitive clini-
cal diagnosis of leukoplakia was made after unsuccess-
ful elimination of suspected aetiological factors or in 
the absence of such factors, assigning Certainty factor 
2. Certainty factor 3 was assigned when histopathologi-
cal examination of an incisional biopsy did not show the 
presence of a definable lesion. In case of an excisional 
biopsy or surgical excision, performed after an incision-
al biopsy, Certainty factor 4 was assigned based on his-
topathological examination of the surgical specimen. 
In 2005, the definition was changed by the WHO into: ‘a 
white plaque of questionable risk having excluded (oth-
er) known diseases or disorders that carry no increased 
risk for cancer’. (8) A list of definable white diseases 
and disorders, that may occur in the mouth, is presented 
in table 1. In case of a predominantly red appearance, 
the term erythroplakia is applied. This entity will not be 
discussed here any further.
The aim of the present study was to evaluate the defini-
tion of oral leukoplakia, proposed by the WHO in 2005 
and taking into account the previously mentioned clas-
sification and staging system (Table 2), including the 
use of a Certainty factor (Table 3). The management re-
sults in these patients, including the issue of malignant 
transformation, will be reported separately. 
Material and Methods
-Patients
For the purpose of this retrospective study, 295 con-
secutive patients were included with a provisional 
clinical diagnosis of oral leukoplakia and being docu-
mented with at least one clinical picture at admission. 
? 1
Lesion Main diagnostic criteria 
Aspirin burn History of local application of aspirin tablets 
Candidasis, pseudomembranous Clinical aspect (pseudomembranes, often symmetrical pattern) 
Frictional lesion Disappearance of the lesion within four weeks after elimination of the suspected mechanical irritation 
(e.g. habit of vigorous toothbrushing); therefore, it is a retrospective diagnosis only 
Hairy leukoplakia Clinical aspect (bilateral localization on the borders of the tongue); histopathology (incl. EBV) 
Lesion caused by a dental restoration (often amalgam) Disappearance of the anatomically closely related (amalgam) restoration within four weeks after its 
replacement; therefore, it is a retrospective diagnosis only 
Leukoedema Clinical aspect (incl. symmetrical pattern) 
Lichen planus Clinical aspect (incl. symmetrical pattern); histopathology is not diagnostic by its own 
Linea alba Clinical aspect (incl. location on the line of occlusion in the cheek mucosa) 
Lupus erythematosus Clinical aspect (incl. symmetrical pattern); almost always cutaneous involvement as well 
Morsicatio (habitual chewing or biting of the cheek, tongue, lips) History of habitual chewing or biting; clinical aspects 
Papilloma and allied lesions, e.g. multifocal epithelial hyperplasia Clinical aspect; histopathology 
Syphilis, secondary ('mucous patches') Clinical aspect; demonstration of T. pallidum; serology 
Smokers' lesion Disappearance of the lesion within four weeks after cessation of the tobacco habits; therefore, it is a 
retrospective diagnosis only 
Smokers' palate ('stomatitis nicotinica') Clinical aspect; history of smoking 
Verrucous carcinoma Histopathology 
White sponge nevus Family history; clinical aspect (often symmetrical pattern) 
   
Table 1.  Definable white diseases and disorders that may occur in the mouth.
Note: There is no consensus in the literature whether or not to recognize a hyperplastic subtype of oral candidasis: some prefer to refer to 
these lesions as Candida-associated leukoplakia. 
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In this study, oral leukoplakia is defined according to 
the WHO 2005 definition. All patients were referred 
to the Department of Oral and Maxillofacial Surgery 
and Oral Pathology at VUmc/ ACTA, Amsterdam, The 
Netherlands between 1997 and 2012. Exclusion criteria 
were patients with a previous or concomitant OSCC (n 
= 20). The remaining group of 275 patients consisted of 
112 men and 163 women, with a mean age of 57 years 
(range 17-98 years).
In 171 patients a possible causative factor was identi-
fied, such as a dental restoration (“contact lesion”), me-
chanical irritation (“frictional lesion”) or tobacco use 
(“smokers’ lesion”), as being defined in table 1. A maxi-
mum of four weeks was observed for evaluation of the 
result of cessation of the suspected causative factor. The 
use of tobacco and alcohol was registered in a simplified 
manner as being user, nonuser or unknown.
The location of the leukoplakia was specified according 
to eight subsites: 1) tongue, 2) floor of mouth (FOM), 
3) lower lip, 4) hard palate, 5) buccal mucosa, 6) upper 
alveolus and gingiva, 7) lower alveolus and gingiva and 
8) multiples sites (Table 4).
Clinically, a distinction was made between homogene-
ous (flat, thin, uniform white in colour) and nonhomo-
geneous (white or white-and-red, - erythroleukoplakia 
- either speckled, granular, nodular or verrucous) (Table 
4). (2) Proliferative verrucous leukoplakia (PVL) is a 
subtype of verrucous leukoplakia, being characterized 
by multifocal presentation, resistance to treatment and a 
high rate of malignant transformation.(9) This subtype 
will not be discussed here any further in detail.
In all cases of a definitive clinical diagnosis of leuko-
plakia, the taking of a biopsy was recommended not 
later than four weeks (Fig. 1). The absence or presence 
? 1
L (size of the leukoplakia) 
L1 Size of single or multiple leukoplakias together <2 cm 
L2 Size of single or multiple leukoplakias together 2-4 cm 
L3 Size of single or multiple leukoplakias together >4 cm 
Lx Size not specified 
P (pathology) 
P0 No epithelial dysplasia (includes "perhaps mild epithelial dysplasia") 
P1 Mild or moderate epithelial dysplasia 
P2 Severe epithelial dysplasia (includes "perhaps carcinoma in situ") 
Px Absence or presence of epithelial dysplasia not specified in the pathology report 
OL-staging system 
Stage 1 L1P0
Stage 2 L2P0
Stage 3 L3P0 or L1L2P1
Stage 4 L3P1 or L P2
General rules of the OL-staging system 
1. If there is doubt concerning the correct L category to which a particular case should be allotted, than the lower (i.e. less 
advanced) category should be chosen. This will also be reflected in the stage grouping. 
2. In case of multiple biopsies of single leukoplakia or biopsies taken from multiple leukoplakias the highest pathological 
score of the various biopsies should be used. 
3. Distinct carcinoma in situ has been excluded from this classification. 
4. For reporting purposes the oral subsite according to the ICD-DA should be mentioned (World Health Organisation, 
International Classification of Diseases. Tenth Revision. Application to Dentistry and Stomatology, ICD-DA, Geneva, 
1992).
Table 2. Classification and staging system for oral leukoplakias (OL-system)2.
? 1
C1 Evidence from a single visit, applying inspection and palpation as the only diagnosis means (Provisional clinical 
diagnosis), including a clinical picture of the lesion. 
C2 Evidence obtained by a negative result of elimination of suspected etiologic factors, e.g. mechanical irritation, during a 
follow-up period of 6 weeks (Definitive clinical diagnosis) 
C3 As C2, but complemented by pretreatment incisional biopsy in which, histopathologically, no definable lesion is 
observed (Histopathologically supported diagnosis)  
C4 Evidence following surgery and pathologically examination of the resected specimen?
Table 3. Certainty (C)-factor of a diagnosis of oral leukoplakia2.
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of epithelial dysplasia has been recorded in three cat-
egories, being 1) no epithelial dysplasia or perhaps mild 
epithelial dysplasia (P0), 2) mild or moderate epithelial 
dysplasia (P1), and 3) severe epithelial dysplasia, possibly 
carcinoma in situ (P2). The size, presence and grade of epi-
thelial dysplasia, if present, were grouped by means of the 
OL-classification and staging system (Table 2). 
The design of this study adheres to the code for proper sec-
? 1
?
?
?
?
?
                             Variable Number 
Gender? Male 
Female?
112
163
Age (years)? Average 
Minimum
Maximum?
57
17
98
Tobacco habits? Use
Non use 
Unknown?
141
117
17
Alcohol consumption? Use
Non use 
Unknown?
123
43
109
Homogeneity? Homogeneous
Non homogeneous?
145
130
Location? Tongue
Floor of mouth 
Lower lip 
Hard palate 
Buccal mucosa 
Upper alv. andgingival 
Lower alv. and gingiva 
Multiple sites?
71
45
13
18
26
26
29
47
?
Table 4. Demographic, aetiologic and clinical data of 275 patients with a 
provisional clinical diagnosis of oral leukoplakia (Certainty factor 1).
DIAGNOSIS OF ORAL LEUKOPLAKIA* 
 (Provisional clinical diagnosis, C 1; n=275)
 (n=171) (n=104) 
 Consider the taking of a biopsy, particularly in case of symptoms No possible cause(s) 
(Definitive clinical diagnosis, C 2)
 In the absence of dysplasia 
 Elimination of possible cause(s), such as mechanical irritation, amalgam restoration Lost to follow-up  
 in direct contact with the white lesion, fungal infection, and tobacco habits (n=4) 
 (maximum 4 weeks to observe the result)  
 Lost to follow-up No response    Biopsy 
  (n=13) (n=148) (n=181; no biopsy within 4 weeks (n=67) 
   (Definitive clinical diagnosis, C 2)
    
      
    
    
 Good response Definitive clinicopathological diagnosis (n=176) 
C 3 (in case of incisional biopsy only (n=91) 
  C 4 (in case of excisional biopsy or surgical 
excision after an incisional biopsy (n=85) 
Definable lesion Nondysplastic leukoplakia Dysplastic leukoplakia Definable lesion  
 (n=10)  (n=114) (n=62) (n=5) 
* C=Certainty factor
Fig.1. DIAGNOSIS OF ORAL LEUKOPLAKIA* (Provisional clinical diagnosis, C 1; n=275)
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ondary use of human tissue of the Dutch Federation of Bio-
medical Scientific Societies (http://www.federa.org). (10)
Results
In this study, 275 patients with a provisional clinical 
diagnosis of oral leukoplakia were included (Certainty 
factor 1). There were 171 white lesions with possible 
causes, such as mechanical irritation, direct contact 
with a dental restoration or tobacco habits. In 10 patients 
a distinct regression or even complete disappearance of 
the lesion was observed. Thirteen patients did not show 
up for the assessment of the elimination of these pos-
sible causes. In the remaining 148 patients no response 
was observed, resulting in a definitive clinical diagno-
sis (Certainty factor 2). In 104 patients there were no 
possible causes, also resulting in a definitive clinical 
diagnosis (Certainty factor 2); four of these patients did 
not show up for the taking of a biopsy. As a result 248 
patients were diagnosed with a Certainty factor 2.
Of the 248 patients with a definitive clinical diagnosis of 
oral leukoplakia, a biopsy was taken in only 181 patients. In 
five patients the histopathological examination resulted in 
a “definable lesion” (Table 1), including two cases of (ver-
rucous) squamous cell carcinoma. In the remaining 176 
patients, 109 incisional biopsies (Certainty factor 3) and 67 
excisional biopsies (Certainty factor 4) were performed. 
Of the 109 patients in whom an incisional biopsy was taken, 
34 showed various degrees of epithelial dysplasia, while in 
75 patients no dysplasia was observed. In these patients 
treatment consisted of additional surgical excision (n = 18), 
CO2 laser vaporisation (n = 33) and observation (n = 58). In 
case of additional surgical excision a specimen was avail-
able for additional histopathological examination. In five 
of the 18 patients the final histopathological examination 
resulted in a different P-classification; four patients were 
upgraded from stage 1 to stage 3, while one patient was 
downgraded from stage 3 to stage 1. 
In 67 patients in whom an excisional biopsy was taken, 
various degrees of epithelial dysplasia have been ob-
served in 28 patients. In the remaining 39 patients no 
dysplasia was observed.
In the 67 patients in whom no possible cause could be 
identified, no biopsy was taken within a period of four 
weeks after the first admission. In some of these pa-
tients a biopsy was taken at a later stage, while others 
were lost to follow-up.
The results of the diagnostic process are shown in (Fig. 
1), while the results of the OL-staging are shown in (Ta-
ble 5).
Discussion
In the present study, 275 patients with a provisional 
clinical diagnosis of oral leukoplakia were included 
(Certainty factor 1). Based on strict definitions only 176 
of the initially 275 patients have been diagnosed with a 
definitive clinicopathological diagnosis of oral leukopla-
kia (Certainty factor 3 or 4). Therefore, the use of strict 
criteria for the diagnosis of leukoplakia is recommended 
in reporting treatment results and also in reporting the 
results of epidemiological studies. 
The taking of a biopsy should be considered before the 
attempt of elimination of a possible cause, particularly 
in case of symptoms. In the past, we have encountered, 
indeed, an occasional patient with a clinical diagnosis of 
leukoplakia in whom a squamous cell carcinoma was al-
ready present in the biopsy taken at the first admission.
It is known that leukoplakia in patients with tobacco 
habits might be reversible if patients give up their smok-
ing habits. (11,12) Therefore, these patients should be 
advised to give up their habits. If successful and if the 
white lesion regresses within a somewhat arbitrarily 
chosen period of no more than four weeks the provision-
al clinical diagnosis of such lesion should, in retrospect, 
be changed into “smokers’ lesion”. It is well appreci-
ated, that it actually may take more than four weeks for 
such a smokers’ lesion to completely disappear. Others 
have shown resolvement of these lesions after cessation 
of the tobacco habits for six weeks. (13) A longer period 
of observation may be allowed provided a prior biopsy 
has not shown the presence of any degree of epithelial 
dysplasia. When the patient is not able or willing to give 
up the tobacco habits and in persistence of the lesion, 
the relevance of applying the term “tobacco-associated 
leukoplakia” seems questionable.
Another possible reversible white lesion is the frictional 
lesion caused by mechanical irritation. This lesion is 
sometimes referred to as “frictional keratosis”. (14-16) 
The term “lesion” is preferred because “keratosis” is 
actually a histopathological term. Similarly as in smok-
ers’ lesion we recommend to restrict a final diagnosis 
of frictional lesion to cases where the lesion has disap-
peared after elimination of the mechanical cause, within 
a somewhat arbitrarily chosen period of no more than four 
weeks. As in a smokers’ lesion, the definitive diagnosis 
of frictional lesion can only be made in retrospect. The 
same applies to “contact lesion” caused by amalgam.
Furthermore, there is room for discussion about the di-
Size L1
L2
L3
87
48
41
Dysplasia P0
P1
P2
  114 
45
17
OL-staging system Stage 1 
Stage 2 
Stage 3 
Stage 4 
55
35
58
28
Table 5. Size, histopathology and stage in 176 patients 
with a definitive clinicopathologic diagnosis of oral 
leukoplakia (Certainty factor 3 or 4).
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agnosis candidiasis versus Candida-associated leuko-
plakia, particularly if located at the commissures of the 
lips and the dorsal surface of the tongue. If such lesions 
regress or disappear after antifungal treatment within 
the previously mentioned period of four weeks there 
is no justification to call such lesions leukoplakias any 
longer. However, in case of persistence, the diagnosis of 
(Candida-associated) leukoplakia remains valid.
Although alcohol might play a role in the aetiology of 
oral leukoplakia, no studies are available in which the 
results of cessation of alcohol habits as a single factor 
has been examined. Perhaps there is such an entity of 
a leukoplakialike lesion caused by alcohol (“alcohol le-
sion”) that disappears after quitting the habit.
In five out of 181 patients with a definitive clinical di-
agnosis of leukoplakia the final diagnosis has been 
changed into papilloma, cheilitis actinica, verrucous 
carcinoma, squamous cell carcinoma, and lichen pla-
nus. As reported elsewhere, (17) we hesitate to accept 
a histopathological diagnosis of lichen planus as a final 
diagnosis. Rather, we prefer the description “compatible 
with lichen planus”. The issue of “lichenoid dysplasia” 
has been thoroughly discussed in the literature. (18) We 
discourage the use of such term since it, erroneously, 
may suggest dysplastic changes in oral lichen planus.
It is well recognized that the assessment of the presence 
and degree of epithelial dysplasia carries some subjectiv-
ity, reflected in a distinct intra- and interobserver varia-
tion. (19,20) In the present study, the absence or presence 
of epithelial dysplasia has been recorded into three cat-
egories, being 1) no or perhaps mild epithelial dysplasia 
(P0), 2) mild or moderate epithelial dysplasia (P1), and 3) 
severe epithelial dysplasia, possibly carcinoma in situ (P2) 
(Table 2). We prefer a three category system above a four 
category system to reduce the intra- and interobserver 
variation between oral pathologists. Therefore, ‘perhaps 
mild epithelial dysplasia’ was included in the first grade. 
In the WHO monograph on Head and Neck Tumours se-
vere epithelial dysplasia is recognized as a separate entity 
form carcinoma in situ. (21) In the present study we have 
followed these recommendations. In case of carcinoma 
in situ the diagnosis of leukoplakia is abandonned (Table 
2). Kujan et al. (22) applies only two histopathological 
grades, being 1) “low risk” (less than four architectural 
changes or less than four cytological changes), and 2) 
“high risk” (at least four architectural changes and five 
cytological changes). In this system, the authors used the 
architectural and cytological changes that have been de-
scribed in the previously mentioned WHO monograph 
(Table 6). (21) At present, there is insufficient justifica-
tion to include one or more biological markers that may 
have predictive value in malignant transformation, such 
as DNA ploidy, in a staging system.
In the 1978 WHO definition of oral leukoplakia it has 
been explicitly stated that the term leukoplakia is unre-
lated to the absence or presence of epithelial dysplasia. 
Therefore, we discourage the use of the term leukopla-
kia as a histopathological term. In case of a biopsy of a 
leukoplakia, the pathologist is advised to always report 
the absence or presence of epithelial dysplasia and its 
degree.
There are actually no strict criteria how to make a dis-
tinction clinically between verrucous leukoplakia and 
verrucous carcinoma. Histopathologically, several pa-
pers have been published about the histopathological 
difference between verrucous hyperplasia and verru-
cous carcinoma, still leaving room for discussion. (23) 
There is also room for discussion about the presently 
proposed classification of the size of a leukoplakia in 
three groups (< 2 cm, 2-4 cm, > 4 cm). In fact, the clas-
sification is more or less based on the T classification of 
oral squamous cell carcinoma. In a study by Holmstrup 
et al. a surface of 200 mm2 was shown to be of relevance 
with regard to the risk of malignant transformation. (24) 
Therefore, one might consider the use of a size classifi-
cation in two groups, being < 200 mm2 or > 200 mm2.
In the sixties of the past century a minimum size of 5 
mm was required before being allowed to use the term 
leukoplakia. (25) Although there may be some practical 
value in re-introducing a minimum size in the defini-
tion of leukoplakia, we hesitate to do so. Another part 
of previous definitions of leukoplakia has been the re-
quirement of a nonremovable nature of the white lesion, 
apparently meant to separate pseudomembranous can-
didiasis from leukoplakia. The adjective “nonremov-
able” seems, indeed, to have some practical value, but 
we do not recommend its re-use at present.
One may consider to include the oral subsite in the stag-
ing system. For instance, in some studies leukoplakias 
of the floor of the mouth and the tongue have been re-
? 1
Architecture 
Irregular epithelial stratification 
Loss of polarity of basal cells 
Drop-shaped rete ridges 
Increased number of mitotic figures 
Abnormal superficial mitoses 
Premature keratinization in single cells (dyskeratosis) 
Keratin pearls within rete pegs 
Cytology
Abnormal variation in nuclear size (anisonucleosis) 
Abnormal variation in nuclear shape (nuclear pleomorphism) 
Abnormal variation in cell size (anisocytosis) 
Abnormal variation in cell shape (cellular pleomorphism) 
Increased nuclear-cytoplasmic ratio 
Increased nuclear size 
Atypical mitotic figures 
Increased number and size of nucleoli 
Hyperchromasia
Table 6. Criteria used for diagnosing dysplasia.21
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ported to more often transform into malignancy than 
leukoplakias at other subsites. However, in other parts 
of the world, e.g. India, leukoplakias at the buccal mu-
cosa are more at risk. Therefore, we do not recommend 
to include the subsite in the staging system.
The clinical distinction between homogeneous and non-
homogeneous leukoplakia has shown to be a valuable 
predictor of possible malignant transformation. (24) In 
daily practice it is difficult to always correctly make the 
distinction between these two types in a reproducible 
manner. The same applies to the various subtypes of non-
homogeneous leukoplakias, such as speckled, nodular, 
granular and also the already mentioned (proliferative) 
verrucous types. Nevertheless, we suggest to maintain 
these descriptions.
The adjectives “premalignant”, “precancerous” and 
“potentially malignant” designate the increased risk 
of malignant transformation. At present, there seem no 
strong reasons to change the WHO preference for the 
use of “potentially malignant”.
It is well appreciated that a number of aspects of the pres-
ently discussed definition and staging system may not be 
equally valid in all parts of the world. We have taken notice 
of a recently proposed classification from India for poten-
tially malignant disorders of the oral cavity. (26) Obvi-
ously, this new classification is not limited to the presently 
discussed entity of leukoplakia, but also includes entities 
such as lichen planus, oral submucous fibrosis, nutritional 
deficiencies and some inherited cancer syndromes.
It is beyond the aim of the present study to further dis-
cuss the possible value of diagnostic adjuncts, e.g. tolui-
dine blue. This also applies to discussion on the various 
treatment modalities and the malignant transformation 
rate. Suggestions for uniform reporting of treatment re-
sults have been discussed elsewhere. (2)
Conclusions
Based on the results of the present study the use of strict 
diagnostic criteria for oral leukoplakia and allied white 
lesions is recommended. Furthermore, the presented 
classification and staging system seems valuable for 
comparing management results of patients with oral 
leukoplakia and also for use in epidemiological studies.
The recommendation is made to modify the present 
WHO definition of oral leukoplakia by adding the re-
quirement of histopathologic examination in order to 
obtain a definitive clinicopathological diagnosis. As a 
result, we suggest: “A predominantly white lesion or 
plaque of questionable behaviour having excluded, clin-
ically and histopathologically, any other definable white 
disease or disorder”. Furthermore, we recommend the 
use of strict diagnostic criteria for predominantly white 
lesions or diseases for which a causative factor has been 
identified, e.g. smokers’ lesion, frictional lesion and 
dental restoration associated lesion.  
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